Lakefront Biotherapeutics NV

€29.62As of Sun 8 Nov 2026, 12:00 UTC
AMS:LKFTHealthcare
Country Netherlands
PE (Fwd) •••
TSR 10Y CAGR (6.09%)
Div yield —
ROE 20.12%
Biotechnology
Beta (5Y) 0.02
PE TTM 3.273
TSR TTM 7.71%
Mkt cap €1.896B
ROIC 87.08%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€35
17.00%
286.47%
Hold 4|12|10|7|5
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.35
0.33
0.32
0.32
21.20%
3.56%
(4.72%)
(1.88%)
Revenue€M
124.0
130.9
135.3
140.7
(0.51%)
7.69%
9.99%
16.81%
Peers (US$2.129B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.743
0.104
0.094
EBIT/Intx
0.105
0.402
0.355
Own earn%
15.57
36.61
18.47
Sh yield%
30.89
48.90
47.87
Owners
Insiders/Inst%
3.53
40.97
Short interest%
2.24
SBC / revenue%
0.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
1–12
$1 testx
—
Incr. ROIC%
2